Extracellular superoxide dismutase exists as an octamer  by Due, Anne V. et al.
FEBS Letters 580 (2006) 1485–1489Extracellular superoxide dismutase exists as an octamer
Anne V. Duea, Steen V. Petersena, Zuzana Valnickovaa, Louise Østergaarda,1, Tim D. Ouryb,
James D. Crapoc, Jan J. Enghilda,*
a Center for Insoluble Protein Structures (inSPIN), Department of Molecular Biology, University of Aarhus, Gustav Wieds Vej 10C,
DK-8000 Aarhus C, Denmark
b Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, United States
c Department of Medicine, National Jewish Medical and Research Center, Denver, CO 80206, United States
Received 11 January 2006; accepted 25 January 2006
Available online 2 February 2006
Edited by Gianni CesareniAbstract Human extracellular superoxide dismutase (EC-
SOD) is involved in the defence against oxidative stress induced
by the superoxide radical. The protein is a homotetramer stabi-
lised by hydrophobic interactions within the N-terminal region.
During the puriﬁcation of EC-SOD from human aorta, we no-
ticed that material with high aﬃnity for heparin–Sepharose
formed not only a tetramer but also an octamer. Analysis of
the thermodynamic stability of the octamer suggested that the
C-terminal region is involved in formation of the quaternary
structure. In addition, we show that the octamer is composed
of both aEC-SOD and iEC-SOD folding variants. The presence
of the EC-SOD octamer with high aﬃnity may represent a way
to inﬂuence the local concentration of EC-SOD to protect tissues
speciﬁcally sensitive to oxidative damage.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The superoxide dismutases (SODs; EC 1.15.1.1) catalyze the
rapid dismutation of two superoxide anions to hydrogen perox-
ide and molecular oxygen [1]. Extracellular SOD (EC-SOD;
SOD3) is a tetramer and present in the extracellular space
and to a lesser extend in the extracellular ﬂuids [2]. In addition,
EC-SOD was recently observed in the nucleus [3]. The N-termi-
nal region of EC-SOD is likely to form an amphipathic a-helix
which is responsible for the formation of tetramers [4,5]. The
importance of hydrophobic interactions in tetramer formation
is illustrated by rat EC-SOD, which exists as a dimer due to the
presence of an Asp residue within this region [6,7]. We have re-
cently shown that the central part of human EC-SOD can exist
in two diﬀerent variants producing subunits with SOD activity
(aEC-SOD) or without (iEC-SOD) [8]. These two variants areAbbreviations: ECM, extracellular matrix; EC-SOD, extracellular su-
peroxide dismutase; TUG-PAGE, Transverse urea-gradient PAGE
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bly, iEC-SOD presents a disulﬁde bridge between two adjacent
cysteine residues [8]. This type of disulﬁde bridge is very rare,
and likely to have a pronounced impact on the tertiary struc-
ture. It is not clear whether these two variants have any impact
on the quaternary structure of EC-SOD. The C-terminal region
of EC-SOD mediates the binding to ligands in the extracellular
matrix (ECM) including heparan sulfate proteoglycans and
type I collagen [9–11]. This region is thus responsible for the
immobilization of EC-SOD and is hence referred to as the
ECM-binding region [11]. Prior to secretion of EC-SOD,
the ECM-binding region can be proteolytically removed by a
two-step event [12–14]. Consequently, both intact and cleaved
EC-SOD subunits are produced. The mature tetramer can be
composed of cleaved subunits only (type A), both intact and
cleaved subunits (type B), or of intact subunits only (type C)
producing EC-SOD with no, intermediate, or high aﬃnity for
the ECM, respectively [15,16]. The ratio between intact and
cleaved subunits is tissue speciﬁc, indicating that the proteolytic
events are regulated [12]. In addition, it has been shown that
the ratio can be modulated by oxidative stress [17–19].
In this study, we show that EC-SOD puriﬁed from human
aorta exists as a major population of tetrameric EC-SOD
and a minor population of octameric EC-SOD estimated to
represent approximately 1% of the puriﬁed material. The
EC-SOD octamer is composed of intact subunits only and pre-
sents an increased aﬃnity for heparin–Sepharose. The stability
of octameric EC-SOD was increased relative to the tetramer,
indicating that the octamer forms a very stable and compact
structure. The presence of an EC-SOD octamer adds to the
ﬂexibility of EC-SOD, and supports the fact that the physio-
logical function of EC-SOD is intricately regulated by the
use of several structural modulations.2. Materials and methods
2.1. Puriﬁcation of octameric EC-SOD
EC-SOD was puriﬁed from human aorta (130 g) as previously
described using heparin aﬃnity chromatography and omitting cation
exchange chromatography [20]. Brieﬂy, a 5 ml HiTrap heparin–Se-
pharose column (Amersham Biosciences) was operated at a ﬂow rate
of 2 ml/min using an FPLC system (Amersham Bioscience). The aorta
homogenate was applied in 20 mM Tris–HCl, 50 mMNaCl, and 5 mM
MgCl2, pH 7.4. The column was subsequently washed in 20 mM Tris–
HCl, 50 mM NaCl, pH 7.4, and bound proteins eluted by using a lin-
ear gradient from 50 mM to 1 M NaCl in 20 mM Tris–HCl, pH 7.4.
Fractions of 2 ml were collected and analysed for protein by SDS–blished by Elsevier B.V. All rights reserved.
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say [21], and for the presence of high molecular weight EC-SOD by
non-denaturing PAGE and Western blotting. Fractions containing
high molecular weight EC-SOD were pooled and dialysed against
20 mM Tris–HCl, pH 7.4. Further fractionation was preformed by an-
ion exchange chromatography using a 1 ml HiTrap Q-Sepharose col-
umn (Amersham Biosciences). The column was equilibrated in
20 mM Tris–HCl, pH 7.4, and the dialyzed sample applied at 1 ml/
min ﬂow rate. The column was washed and proteins eluted using a lin-
ear gradient from 0 to 500 mM NaCl in 20 mM Tris–HCl, pH 7.4.
Fractions of 1 ml were collected and analysed as described above.
The fractions containing high molecular weight EC-SOD were pooled
and stored at 20 C until further use.
2.2. Polyacrylamide gel electrophoresis
SDS–PAGE and non-denaturing PAGE was performed as previ-
ously described [20]. Transverse urea-gradient PAGE (TUG-PAGE)
was preformed by using 7% acrylamide gels with a horizontal and lin-
ear gradient from 0 to 8 M urea [22]. Electrophoresis was carried out
using the same buﬀer system as for non-denaturing PAGE and the
samples were prepared accordingly. The activity of the separated mate-
rial was assessed by activity staining [20] or Western blotting by using a
polyclonal rabbit anti-human EC-SOD antiserum and HRP-conju-
gated goat anti-rabbit Ig [8].
2.3. Analytical size exclusion chromatography
EC-SOD was subjected to analytical size exclusion chromatography
using a Superose 6 PC 3.2/30 column (Amersham Biosciences) at-
tached to a SMART system (Pharmacia). The column was equilibrated
in 20 mM Tris–HCl, 150 mMNaCl, pH 7.4, and operated at 40 ll/min.
Approximately 10 lg protein was applied in a volume of 20 ll. The
protein elution was monitored by absorbance at 280 nm. Fractions
were collected manually and analysed by non-denaturing PAGE and
Western blotting. The column was calibrated by assessing the elution
volume (Ve) of the following globular protein standards: thyroglobin
(669 kDa), ferritin (440 kDa), adolase (158 kDa), bovine serum albu-
min (67 kDa), ribonuclease A (13.7 kDa) (HMW and LMW gel ﬁltra-
tion calibration kit, Amersham Biosciences). The void volume of the
column (Vo) was determined as the elution volume of blue dextran
(2000 kDa). The coeﬃcient Kav was calculated according to the equa-
tion Kav = (Ve  Vo)/(Vt  Vo), where Vt is the total column volume
(2.4 ml). A plot of Kav versus Log (MW) was used to estimate the size
of EC-SOD.
2.4. Mass spectrometric identiﬁcation of aEC-SOD and iEC-SOD
The collected fraction from size exclusion chromatography contain-
ing octameric EC-SOD was lyophilized and resuspended in 100 ll of
25 mM Tris–HCl, pH 7.4, containing 2.5 M guanidinium hydrochlo-
ride, 20 mM 8-hydroxyquinoline, and 25 mM iodoacetamide. The
sample was left for 2 h at 23 C to allow for the alkylation of free cys-
teine residues. The buﬀer was subsequently exchanged using a Fast
Desalting PC 3.2/10 column (Amersham Biosciences) connected to
the SMART system and operated in 50 mM NH4HCO3 at a ﬂow of
200 ll/min. The collected S-carboxymethylated protein was digested
over night at 37 C using porcine trypsin at an approximate weight ra-
tio of 1:40. The peptides were reduced by the addition of 20 mM DTT
and subsequently absorbed by using a C18 reverse-phase ZipTip (Mil-
lipore) according to manufacturer’s instructions. Bound peptides were
eluted and spotted on a sample plate using 1 ll of a saturated matrix
solution (0.4% (w/v) a-cyano-4-hydroxycinnamic acid in 70% (v/v) ace-
tonitrile, 0.1% (v/v) triﬂuoroacetic acid). The peptides were analyzed
by matrix assisted laser desorption/ionization mass spectrometry
(MALDI-MS) using a quadropole/time-of-ﬂight (QTOF) Ultima Glo-
bal mass spectrometer (Micromass) as previously described [23].3. Results
3.1. EC-SOD type C forms two distinct quaternary structures
When EC-SOD extracted from human aorta tissue was sub-
jected to heparin–Sepharose aﬃnity chromatography, the
majority eluted between 380 and 550 mM NaCl (Fig. 1A)[20]. A minor fraction of the material (1% as evaluated by
SOD activity) expressed a higher heparin aﬃnity and eluted
in subsequent fractions (600–650 mM NaCl) (Fig. 1A). Analy-
sis by reducing SDS–PAGE showed that the major peak con-
tained both intact and cleaved subunits whereas the material
with higher heparin aﬃnity consisted of intact subunits only
(Fig. 1B). EC-SOD in the major peak corresponded to type
B EC-SOD whereas the minor fraction of EC-SOD repre-
sented type C. Analysis by non-reducing SDS–PAGE showed
that type B EC-SOD is composed of dimeric and monomeric
subunits whereas type C consisted of dimers only (Fig. 1C).
This ﬁnding corroborates previous reports showing that the in-
tact subunit has the capacity to form an inter-subunit disulﬁde
bond [8,20,24,25]. To investigate the quaternary structure of
the collected material, we analyzed the fractions by non-dena-
turing PAGE (Fig. 2). Fractions representing type B EC-SOD
migrated as a tetramer, however, the fractions representing
type C EC-SOD were found to contain both a tetramer and
a higher molecular weight species (Fig. 2). This species was
repeatedly observed during separate puriﬁcations using dis-
tinct starting material. These results show that EC-SOD com-
posed of intact subunits form molecules of two distinct
quaternary structures.
3.2. EC-SOD of high molecular weight is an octamer
In order to corroborate the size estimated by non-denatur-
ing PAGE, the high molecular weight material was subjected
to analytical size exclusion chromatography (Fig. 3).
Although the applied material did not separate into two
distinct peaks, two fractions were manually collected and de-
noted fraction 1 and 2 (Fig. 3). The size of EC-SOD collected
in fraction 1 and fraction 2 was estimated to be 270 and
150 kDa, respectively (Fig. 3). As the mass of the intact EC-
SOD subunit is 33 kDa, the material collected in fraction 1
is estimated to be octameric whereas EC-SOD in fraction 2
represents a tetramer. When fraction 1 was analysed by
non-denaturing PAGE a single band corresponding to the
octameric EC-SOD was detected (Fig. 3, inset; lane 2). Anal-
ysis of fraction 2 by non-denaturing PAGE produced two
bands including tetrameric EC-SOD and octameric EC-SOD
(Fig. 3, inset; lane 3). The presence of octameric EC-SOD is
likely due to the inability to achieve suﬃcient separation.
The data supports the result obtained by non-denaturing
PAGE and we conclude that EC-SOD type C exists as both
a tetramer and an octamer.
3.3. Octamerization of EC-SOD leads to enhanced stability
To further characterize octameric EC-SOD, we investigated
the conformational stability by denaturant-induced unfolding
using TUG-PAGE analysis. The puriﬁed material represent-
ing both tetrameric and octameric EC-SOD was subjected
to TUG-PAGE using a horizontal gradient from 0 to 8 M
urea. The migration patterns of the proteins were detected
by Western blotting. Low concentrations of urea had no eﬀect
on the electrophoretic mobility of tetrameric EC-SOD
(Fig. 4). However, at approximately 5 M urea the mobility
was reduced. At concentrations of urea above the transition
no mobility change was observed (Fig. 4). In contrast, octa-
meric EC-SOD showed a marked increase of stability and
was not aﬀected by 8 M urea. This ﬁnding suggests that the
EC-SOD octamer has gained conformational stability as com-
pared to the tetramer composed of intact subunits only. It is
Fig. 1. Heparin–Sepharose chromatography. (A) An aorta homogenate was applied to a heparin–Sepharose column and proteins eluted with a linear
gradient of NaCl (stippled line). Protein was detected by absorbance at 280 nm. SOD activity measured by the oxidase/cytochrome c assay. Fractions
were subjected to SDS–PAGE analysis under reducing (B) and non-reducing (C) conditions and EC-SOD subsequently detected by Western blotting.
Puriﬁed EC-SOD was included as a control (C) in both conditions. The position of intact and cleaved subunits (reducing conditions) and the
monomer and dimer (non-reducing conditions) are indicated on the left. The horizontal bars in all panels indicate the fractions pooled for further
analysis.
Fig. 2. Analysis of quaternary structure by non-denaturing PAGE.
Fractions analyzed by SDS–PAGE (Fig. 1) were also subjected to non-
denaturing PAGE to determine the subunit composition. The analysis
was performed using approximately the same amount of SOD activity.
EC-SOD was subsequently detected by Western blotting. Arrows
indicate the positions of tetrameric and high molecular weight (HMW)
EC-SOD in the gel. The fractions pooled for further analysis are
indicated by the horizontal bar. The position of molecular weight
markers are indicated on the left.
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the octamer is maintained across the full range of urea con-
centrations as assessed by activity staining (data not shown)suggesting that the unfolding of the tetramers do not involve
the catalytic region.
3.4. The EC-SOD octamer is composed of both aEC-SOD and
iEC-SOD subunits
The EC-SOD octamer puriﬁed by size exclusion chromatog-
raphy (Fig. 3, inset; lane 2) was used to investigate if the for-
mation of the octamer depends on the EC-SOD folding
variants (aEC-SOD only, iEC-SOD only, or both). The mate-
rial was incubated with iodoacetamide to alkylate free cysteine
residues and the alkylated material was subsequently digested
with trypsin. The resulting peptides were reduced with DTT
and analyzed by MALDI-MS. Peptides derived from aEC-
SOD and iEC-SOD show diﬀerent mass ﬁngerprints as the po-
sition of the single free cysteine residue is diﬀerent in the two
forms (aEC-SOD, Cys195; iEC-SOD, Cys45) [8]. Hence, the
identiﬁcation of S-carboxymethylated peptides (+57 Da) at
Cys19 or Cys45, reveal the presence of aEC-SOD or iEC-
SOD, respectively. The remaining cysteine residues in both
aEC-SOD and iEC-SOD are involved in disulﬁde bonds dur-
ing alkylation and are not derivatized. Both peptides contain-
ing Cys45 and Cys195 were detected with and without a mass
increase of 57 Da (data not shown). This ﬁnding indicates that
the octamer contains both folding variants and that there is no
structural constraints of either aEC-SOD or iEC-SOD to par-
ticipate in the formation of octameric EC-SOD.
Fig. 3. Analytical size exclusion chromatography. The pooled material containing both tetrameric and high molecular weight EC-SOD was applied
to a Superose 6 PC 3.2/30 column. Protein elution was detected by absorption at 280 nm. The two fractions collected were analyzed by non-
denaturing PAGE/Western blotting as indicated (inset). Lane 1 represents the pooled material applied to the column. The analysis indicates that the
EC-SOD octamer has a globular shape.
Fig. 4. Transverse urea-gradient PAGE of puriﬁed EC-SOD. The
pooled material containing EC-SOD of both quaternary structures was
applied across the top of a 7% polyacrylamide TUG gel with a
horizontal linear gradient of urea as indicated. EC-SOD was detected
by Western blotting. The position of tetrameric and octameric EC-
SOD is indicated by arrows. The shapes of the bands suggest that the
EC-SOD octamer is more stable than the tetramer.
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During the puriﬁcation of EC-SOD from human aorta ex-
tracts, we have consistently observed a high molecular weight
form with an increased aﬃnity for heparin–Sepharose. This
species has been observed in separate puriﬁcations using dis-
tinct starting material. Here we show that the high molecular
weight EC-SOD is an octamer composed of intact subunits
only, indicating that type C EC-SOD can exist as both a tetra-
mer and an octamer. We have previously published that type B
EC-SOD puriﬁed from human aorta and mouse lungs formmultimers [20]. However, subsequent analyses have shown that
these multimers were induced by the low pH (4.8) used during
cation exchange chromatography (data not shown). In this re-
port, we have subjected the aortic extract to puriﬁcation steps
at neutral pH only. In addition, it should be stressed that the
EC-SOD octamer is observed only in the late fractions col-
lected from the heparin–Sepharose and not in the major peak
containing type B EC-SOD (Fig. 2). It does not appear that the
octamer and tetramer is in a dynamic equilibrium, as we did
not observe any tetramer in the puriﬁed octameric material
upon storage. Moreover, we did not observe any dissociation
of the octamer by varying ionic strength or pH, suggesting that
the octameric structure is not stabilized by ionic interactions
(results not shown).
The ﬁnding that only the intact EC-SOD subunit has the
capacity to generate the octamer, suggests that the ECM-bind-
ing regions are involved in the stabilization. This notion is sup-
ported by thermodynamic stability studies using TUG-PAGE
analysis. If tetrameric EC-SOD composed of intact subunits
are dissociated by urea the migration of the protein will in-
crease and be represented by a band corresponding to the di-
mer (70 kDa). However, the ﬁnding that the migration of
tetrameric EC-SOD is reduced at concentrations above 5 M
urea suggests that the N-terminal interactions are maintained.
The stability of the tetramer in the presence of strong denatur-
ants such as 5 M guanidinium hydrochloride or 8 M urea has
previously been noted [4,26]. The enzymatic activity of EC-
SOD is also maintained in TUG-PAGE analysis (0–8 M urea)
(data not shown). The structure of the central part of the pro-
tein is essential for activity, suggesting that the structural per-
turbation observed at concentrations above 5 M urea only
involves unfolding of the ECM-binding regions. However,
the migration of octameric EC-SOD is not aﬀected by urea.
This indicates that the octamer is relatively more stable than
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actions between the ECM-binding regions in the EC-SOD oct-
amer. The presence of both aEC-SOD and iEC-SOD in the
octamer indicates that there are not structural requirements
for the presence of one form only.
In the extracellular space, the EC-SOD octamer is likely to
bind strongly to type I collagen and heparan sulfate, based
on the presence of eight ECM-binding regions. We have previ-
ously shown that the intracellular cleavage of the ECM-bind-
ing region is tissue speciﬁc [12]. Liver and lungs were found
to contain equal amounts of the cleaved and intact subunits,
supporting the generation of type B EC-SOD. However, or-
gans like brain and heart contain mainly intact subunits [12],
supporting the formation of tetrameric and octameric type C
EC-SOD. Due to a relatively low aﬃnity for the ECM, we
hypothesize that type B EC-SOD diﬀuse into the tissue from
the site of synthesis to confer global protection against damage
induced by the superoxide radical. In contrast, type C with a
relative high aﬃnity for the ECM, is likely to be localized at
the site of synthesis. The formation of octameric EC-SOD sup-
port maximum ECM-binding capacity and may thus reﬂect
virtually immobilized EC-SOD. The ﬁnding that heart and
brain largely contain intact subunits may reﬂect the physiolog-
ical importance of superoxide protection in these tissues.
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